USFDA accepts Sun Pharma’s psoriasis drug application
Sun Pharmaceutical Industries has said that the US heath regulator has accepted biologics licence application (BLA) for tildrakizumab for the treatment of psoriasis. Sun Pharma...
Tag : psoriasis
Sun Pharma, Almirall have entered into an agreement for psoriasis novel biologic
Sun Pharmaceutical and Almirall which is a Spanish firm have entered into a licencing agreement for development and commercialisation of tildrakizumab which is used to...